Form 4: Glaukos Officer Sells Shares Under 10b5-1 Plan

Glaukos Corp. Chief Development Officer Tomas Navratil sold shares valued at over $1.3 million under a pre-arranged trading plan.

Summary

• Tomas Navratil, Chief Development Officer at Glaukos Corp. (GKOS), reported transactions on April 10, 2026.
• These transactions involved the sale of common stock under a Rule 10b5-1 trading plan adopted on March 12, 2026.
• A total of 1,881 shares were sold across multiple transactions at weighted average prices ranging from $116.72 to $120.23.
• The total value of the reported sales is approximately $1,370,000.
• Following these transactions, Navratil beneficially owns 90,370 shares of common stock, which includes 39,791 unvested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; while it involves a significant sale of shares by a key executive, it was executed under a pre-arranged 10b5-1 plan, mitigating concerns about opportunistic selling.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-impactful transactions.
• The reporting person continues to hold a significant number of shares (90,370) after the sales, including unvested restricted stock units.

Negatives

• The company's Chief Development Officer sold a notable number of shares, which could be perceived negatively by the market.
• The total value of shares sold exceeds $1.3 million.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a pre-arranged plan.
• The unvested restricted stock units (39,791) represent a portion of the reporting person's compensation that is not yet realized.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports past transactions.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, is a common event for executives and can sometimes be interpreted by the market as a signal of management's confidence in the company's future prospects, or simply as a means for executives to diversify their personal holdings.

Stakeholder Impact

• Shareholders: May interpret the sale as a negative signal, although the 10b5-1 plan mitigates this concern. The continued holding of a large number of shares and unvested RSUs suggests ongoing commitment.
• Employees: May view the sale as a sign of confidence or as a standard executive financial planning activity.
• Management: The sale is a personal financial decision by an executive, executed within regulatory frameworks.

Next Steps

• The reporting person may continue to execute transactions under the existing Rule 10b5-1 plan.
• The company may provide further updates on executive compensation or stock ownership in future filings.

Key Dates

Keywords

Glaukos Corp, GKOS, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Beneficial Ownership, Restricted Stock Units, Tomas Navratil, SEC Filing